P301L and P301S are also the most widely used MAPT mutations in transgenic mouse models of tauopathies, because their overexpression gives rise to robust phenotypes consisting of tau hyperphosphorylation, filament formation and neurodegeneration [25–28]. Here, MAPT is linked to tauopathy.